Science Explorer Back to mapMap
Discussion
Researcher · Symphogen (Denmark) · Denmark

Per‐Johan Meijer

Per‐Johan Meijer publishes mostly in Molecular Biology, Plant Science and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Plant-Microbe Interactions and Immunity.

OpenAlex
World rank
#2,135,138
of 7,710,434 ranked researchers
Rank in Denmark
#16,079
of 43,819
Works
22
Citations
1.8k
Citations per work
82.5
h-index
9
i10-index 8Top 82% in Molecular Biology
Per‐Johan Meijer

What does Per‐Johan Meijer research?

Per‐Johan Meijer's work is mostly in Biochemistry, Genetics and Molecular Biology (28%), Medicine (28%), Agricultural and Biological Sciences (21%).

Life Sciences: 13 works · 57.5% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 27.7% of their workMolecular Biology: 6 works · 27.7% of their workAgricultural and Biological Sciences: 5 works · 21.3% of their workPlant Science: 5 works · 21.3% of their workImmunology and Microbiology: 2 works · 8.5% of their workImmunology: 2 works · 8.5% of their workHealth Sciences: 6 works · 27.7% of their workMedicine: 6 works · 27.7% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 17.0% of their workOncology: 1 works · 6.4% of their workCardiology and Cardiovascular Medicine: 1 works · 4.3% of their workEverything else: 3 works · 14.8% of their workTHEIR WORKPer‐Johan Meijer22works
Life Sciences58%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology627.7%
    2. Agricultural and Biological Sciences521.3%
    3. Immunology and Microbiology28.5%
    1. Medicine627.7%
  3. Everything else314.8%
  1. 1Molecular Biology28% of their works
  2. 2Plant Science21% of their works
  3. 3Radiology, Nuclear Medicine and Imaging17% of their works
  4. 4Immunology8% of their works
  5. 5Oncology6% of their works
  6. 6Cardiology and Cardiovascular Medicine4% of their works

Research topics

Which keywords describe Per‐Johan Meijer's research?

The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Protein Aggregation and Antioxidants.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Monoclonal Antibodies122 topics
  2. Therapeutic Antibodies122 topics
  3. Glycosylation102 topics
  4. Antibody Engineering81 topic
  5. Fc Receptors81 topic
  6. Biopharmaceuticals41 topic
  7. Protein Aggregation41 topic
  8. Antioxidants31 topic
  9. Plant Immunity31 topic
  10. Reactive Oxygen Species31 topic
  11. Rhizosphere Interactions31 topic
  12. Cancer21 topic
  13. Foxp321 topic
  14. Glycans21 topic
  15. Light Harvesting21 topic
  16. Mutation Breeding21 topic
  17. Photosystem II21 topic
  18. TGF-ß21 topic
  19. TILLING21 topic

Where does Per‐Johan Meijer work?

Per‐Johan Meijer's main affiliation in the publication record is Symphogen (Denmark), Denmark.

How many publications and citations does Per‐Johan Meijer have?

OpenAlex counts 22 works and 1,814 citations for Per‐Johan Meijer, an h-index of 9, ranking #2,135,138 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Per‐Johan Meijer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.